Skip to main content

Advertisement

SpringerLink
Log in

Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

The prognostic role of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinoma (HNSCC) remains controversial. The goal of this study was to summarize existing evidence regarding whether EGFR overexpression is a prognostic factor in HNSCC. Relevant studies were identified using Pubmed, Ovid, and Web of Science databases. A meta-analysis was conducted on the prognostic value of EGFR expression for overall survival (OS) and disease-free survival (DFS). Thirty-seven studies were included. Primary analysis indicated that EGFR overexpression was associated with reduced OS (hazard ratio [HR]: 1.694, 95 % confidence interval [CI]: 1.432–2.004). DFS, on the other hand, was not associated with EGFR expression after adjusting for publication bias (HR: 1.084, 95 % CI: 0.910–1.290). Subgroup analysis gave a statistically significant pooled HR for OS in laryngeal carcinoma (HR: 2.519, 95 % CI: 1.615–3.928) and in oropharyngeal carcinoma (HR: 2.078, 95 % CI: 1.605–2.690). The pooled HR was statistically significant for DFS with respect to oropharyngeal carcinoma (HR: 1.055, 95 % CI: 1.020–1.092), but not laryngeal carcinoma (HR: 1.750, 95 % CI: 0.911–3.360). When dividing studies based on the immunohistochemistry (IHC) scoring system, only the group that evaluated EGFR expression according to the intensity and extent of staining showed no between-study heterogeneity for both OS and DFS. Overall, EGFR overexpression was associated with shortened OS, but not DFS. Future studies are needed that stratify patients by specific tumor sites. Furthermore, when estimating protein level by the IHC method, it is advisable to consider both intensity and extent of staining.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29. doi:10.3322/caac.20138.

    Article  PubMed  Google Scholar 

  2. Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med. 2008;359(11):1143–54. doi:10.1056/NEJMra0707975.

    Article  PubMed  CAS  Google Scholar 

  3. Kundu SK, Nestor M. Targeted therapy in head and neck cancer. Tumour Biol J Int Soc Oncodevelopmental Biol Med. 2012;33(3):707–21. doi:10.1007/s13277-012-0350-2.

    Article  CAS  Google Scholar 

  4. Zhang S, Chen J, Jiang H, Ma H, Yang B. Anti-epidermal growth factor receptor therapy for advanced head and neck squamous cell carcinoma: a meta-analysis. Eur J Clin Pharmacol. 2012;68(5):561–9. doi:10.1007/s00228-011-1194-1.

    Article  PubMed  CAS  Google Scholar 

  5. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011;11(1):9–22. doi:10.1038/nrc2982.

    Article  PubMed  CAS  Google Scholar 

  6. Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology. 2009;77(6):400–10. doi:10.1159/000279388.

    Article  PubMed  CAS  Google Scholar 

  7. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993;53(15):3579–84.

    PubMed  CAS  Google Scholar 

  8. Dorsey K, Agulnik M. Promising new molecular targeted therapies in head and neck cancer. Drugs. 2013. doi:10.1007/s40265-013-0025-3.

    PubMed  Google Scholar 

  9. Chan AT, Felip E. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol/ESMO. 2009;20 Suppl 4:123–5. doi:10.1093/annonc/mdp150.

    Google Scholar 

  10. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–34.

    Article  PubMed  CAS  Google Scholar 

  11. Steels E, Paesmans M, Berghmans T, Branle F, Lemaitre F, Mascaux C, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis. Eur Respir J. 2001;18(4):705–19.

    Article  PubMed  CAS  Google Scholar 

  12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  13. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101.

    Article  PubMed  CAS  Google Scholar 

  14. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–63.

    Article  PubMed  CAS  Google Scholar 

  15. Issing WJ, Liebich C, Wustrow TP, Ullrich A. Coexpression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer. Anticancer Res. 1996;16(1):283–8.

    PubMed  CAS  Google Scholar 

  16. Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst. 1998;90(11):824–32.

    Article  PubMed  CAS  Google Scholar 

  17. Maurizi M, Ferrandina G, Almadori G, Scambia G, Cadoni G, D'Agostino G, et al. Prognostic significance of methyl-p-hydroxy-phenyllactate-esterase activity in laryngeal squamous cell carcinoma. Br J Cancer. 1998;77(8):1253–9.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  18. Maiorano E, Favia G, Maisonneuve P, Viale G. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. J Pathol. 1998;185(2):167–74. doi:10.1002/(SICI)1096-9896(199806)185:2<167::AID-PATH70>3.0.CO;2-E.

    Article  PubMed  CAS  Google Scholar 

  19. Etienne MC, Pivot X, Formento JL, Bensadoun RJ, Formento P, Dassonville O, et al. A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil. Br J Cancer. 1999;79(11–12):1864–9. doi:10.1038/sj.bjc.6690297.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  20. Xia W, Lau YK, Zhang HZ, Xiao FY, Johnston DA, Liu AR, et al. Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res Off J Am Assoc Cancer Res. 1999;5(12):4164–74.

    CAS  Google Scholar 

  21. Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, et al. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2001;127(7):780–5.

    PubMed  CAS  Google Scholar 

  22. Aebersold DM, Froehlich SC, Jonczy M, Beer KT, Laissue J, Greiner RH, et al. Expression of transforming growth factor-alpha, epidermal growth factor receptor and platelet-derived growth factors A and B in oropharyngeal cancers treated by curative radiation therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2002;63(3):275–83.

    Article  CAS  Google Scholar 

  23. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res. 2002;62(24):7350–6.

    PubMed  CAS  Google Scholar 

  24. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer. 2003;89(4):681–6. doi:10.1038/sj.bjc.6601171.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  25. Pivot X, Magne N, Guardiola E, Poissonnet G, Dassonville O, Francoual M, et al. Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer. Oral Oncol. 2005;41(3):320–7. doi:10.1016/j.oraloncology.2004.09.011.

    Article  PubMed  CAS  Google Scholar 

  26. Shiraki M, Odajima T, Ikeda T, Sasaki A, Satoh M, Yamaguchi A, et al. Combined expression of p53, cyclin D1 and epidermal growth factor receptor improves estimation of prognosis in curatively resected oral cancer. Mod Pathol Off J U S Can Acad Pathol Inc. 2005;18(11):1482–9. doi:10.1038/modpathol.3800455.

    CAS  Google Scholar 

  27. Kong A, Leboucher P, Leek R, Calleja V, Winter S, Harris A, et al. Prognostic value of an activation state marker for epidermal growth factor receptor in tissue microarrays of head and neck cancer. Cancer Res. 2006;66(5):2834–43. doi:10.1158/0008-5472.CAN-05-2994.

    Article  PubMed  CAS  Google Scholar 

  28. Smid EJ, Stoter TR, Bloemena E, Lafleur MV, Leemans CR, van der Waal I, et al. The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2006;65(5):1323–9. doi:10.1016/j.ijrobp.2006.03.011.

    Article  PubMed  CAS  Google Scholar 

  29. Laimer K, Spizzo G, Gastl G, Obrist P, Brunhuber T, Fong D, et al. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol. 2007;43(2):193–8. doi:10.1016/j.oraloncology.2006.02.009.

    Article  PubMed  CAS  Google Scholar 

  30. Reimers N, Kasper HU, Weissenborn SJ, Stutzer H, Preuss SF, Hoffmann TK, et al. Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer. Int J Cancer. 2007;120(8):1731–8. doi:10.1002/ijc.22355.

    Article  PubMed  CAS  Google Scholar 

  31. Diniz-Freitas M, Garcia-Caballero T, Antunez-Lopez J, Gandara-Rey JM, Garcia-Garcia A. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma. Oral Dis. 2007;13(3):285–90. doi:10.1111/j.1601-0825.2006.01280.x.

    Article  PubMed  CAS  Google Scholar 

  32. Kumar B, Cordell KG, Lee JS, Worden FP, Prince ME, Tran HH, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol. 2008;26(19):3128–37. doi:10.1200/JCO.2007.12.7662.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Jiang H, Yang BB. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy. Acta Otolaryngol. 2009;129(1):101–7. doi:10.1080/00016480802054185.

    Article  PubMed  CAS  Google Scholar 

  34. Ryott M, Wangsa D, Heselmeyer-Haddad K, Lindholm J, Elmberger G, Auer G, et al. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma. Eur J Cancer. 2009;45(9):1700–8. doi:10.1016/j.ejca.2009.02.027.

    Article  PubMed  CAS  Google Scholar 

  35. Shah NG, Trivedi TI, Tankshali RA, Goswami JV, Jetly DH, Shukla SN, et al. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Head Neck. 2009;31(12):1544–56. doi:10.1002/hed.21126.

    Article  PubMed  Google Scholar 

  36. Farhadieh RD, Salardini A, Rees CG, Russell PJ, Yang JL, Smee R. Protein expression of epidermal growth factor receptor in laryngeal squamous cell carcinoma index tumors correlates with diagnosis of second primary tumors of the upper aero-digestive tract. Ann Surg Oncol. 2009;16(10):2888–94. doi:10.1245/s10434-009-0649-4.

    Article  PubMed  Google Scholar 

  37. Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27(36):6213–21. doi:10.1200/JCO.2009.23.1670.

    Article  PubMed  Google Scholar 

  38. Al-Swiahb JN, Huang CC, Fang FM, Chuang HC, Huang HY, Luo SD, et al. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area. Arch Otolaryngol Head Neck Surg. 2010;136(5):502–8. doi:10.1001/archoto.2010.47.

    Article  PubMed  Google Scholar 

  39. Hong A, Dobbins T, Lee CS, Jones D, Jackson E, Clark J, et al. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer. 2010;46(11):2088–96. doi:10.1016/j.ejca.2010.04.016.

    Article  PubMed  CAS  Google Scholar 

  40. Numico G, Russi EG, Colantonio I, Lantermo RA, Silvestris N, Vitiello R, et al. EGFR status and prognosis of patients with locally advanced head and neck cancer treated with chemoradiotherapy. Anticancer Res. 2010;30(2):671–6.

    PubMed  CAS  Google Scholar 

  41. Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, et al. Comparative prognostic value of epidermal growth factor quantitative protein expression compared with FISH for head and neck squamous cell carcinoma. Clin Cancer Res Off J Am Assoc Cancer Res. 2011;17(9):2947–54. doi:10.1158/1078-0432.CCR-10-2040.

    Article  CAS  Google Scholar 

  42. Young RJ, Rischin D, Fisher R, McArthur GA, Fox SB, Peters LJ, et al. Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1230–7. doi:10.1158/1055-9965.EPI-10-1262.

    Article  PubMed  CAS  Google Scholar 

  43. Nakata Y, Uzawa N, Takahashi K, Sumino J, Michikawa C, Sato H, et al. EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomas. Eur J Cancer. 2011;47(15):2364–72. doi:10.1016/j.ejca.2011.07.006.

    Article  PubMed  CAS  Google Scholar 

  44. Trivedi TI, Tankshali RA, Goswami JV, Shukla SN, Shah PM, Shah NG. Identification of site-specific prognostic biomarkers in patients with oral squamous cell carcinoma. Neoplasma. 2011;58(3):217–26.

    Article  PubMed  CAS  Google Scholar 

  45. Lindquist D, Ahrlund-Richter A, Tarjan M, Tot T, Dalianis T. Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. 2012;32(1):153–61.

    PubMed  Google Scholar 

  46. Nichols AC, Whelan F, Basmaji J, Dhaliwal S, Dowthwaite S, Chapeskie C, et al. Ki-67 expression predicts radiotherapy failure in early glottic cancer. J Otolaryngol Head Neck Surg Le Journal d'oto-rhino-laryngologie et de Chirurgie Cervico-Faciale. 2012;41(2):124–30.

    Google Scholar 

  47. Won HS, Jung CK, Chun SH, Kang JH, Kim YS, Sun DI, et al. Difference in expression of EGFR, pAkt, and PTEN between oropharyngeal and oral cavity squamous cell carcinoma. Oral Oncol. 2012;48(10):985–90. doi:10.1016/j.oraloncology.2012.04.013.

    Article  PubMed  CAS  Google Scholar 

  48. Monteiro LS, Diniz-Freitas M, Garcia-Caballero T, Warnakulasuriya S, Forteza J, Fraga M. Combined cytoplasmic and membranous EGFR and p53 overexpression is a poor prognostic marker in early stage oral squamous cell carcinoma. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2012;41(7):559–67. doi:10.1111/j.1600-0714.2012.01142.x.

    Google Scholar 

  49. Rahimi AS, Wilson DD, Saylor DK, Stelow EB, Thomas CY, Reibel JF, et al. p16, Cyclin D1, and HIF-1alpha predict outcomes of patients with oropharyngeal squamous cell carcinoma treated with definitive intensity-modulated radiation therapy. Int J Otolaryngol. 2012;2012:685951. doi:10.1155/2012/685951.

    Article  PubMed Central  PubMed  Google Scholar 

  50. Lundberg M, Leivo I, Saarilahti K, Makitie AA, Mattila PS. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma. Acta Otolaryngol. 2012;132(9):1006–12. doi:10.3109/00016489.2012.678944.

    Article  PubMed  CAS  Google Scholar 

  51. Huang SF, Cheng SD, Chien HT, Liao CT, Chen IH, Wang HM, et al. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma. Oral Oncol. 2012;48(1):67–72. doi:10.1016/j.oraloncology.2011.06.511.

    Article  PubMed  CAS  Google Scholar 

  52. Greene FL, Page DL, Fleming, et al. AJCC cancer staging mannual. 6th ed. New York: Springer-Verlag; 2002.

    Book  Google Scholar 

  53. Administration USFaD. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm278894.htm.

  54. Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res. 2003;63(6):1179–82.

    PubMed  CAS  Google Scholar 

  55. Takes RP, Baatenburg de Jong RJ, Schuuring E, Litvinov SV, Hermans J, Van Krieken JH. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell. Anticancer Res. 1998;18(6B):4793–800.

    PubMed  CAS  Google Scholar 

  56. Berrino F, Gatta G. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. EUROCARE Working Group. Eur J Cancer. 1998;34(14 Spec No):2154–61.

    Article  PubMed  CAS  Google Scholar 

  57. Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer. 2005;114(5):806–16. doi:10.1002/ijc.20740.

    Article  PubMed  CAS  Google Scholar 

  58. Smith RR, Caulk R, Frazell E, Holinger PH, MacComb WS, Russell WO, et al. Revision of the clinical staging system for cancer of the larynx. Cancer. 1973;31(1):72–80.

    Article  PubMed  CAS  Google Scholar 

  59. Stambuk HE, Karimi S, Lee N, Patel SG. Oral cavity and oropharynx tumors. Radiol Clin N Am. 2007;45(1):1–20. doi:10.1016/j.rcl.2006.10.010.

    Article  PubMed  Google Scholar 

  60. Udeabor SE, Rana M, Wegener G, Gellrich NC, Eckardt AM. Squamous cell carcinoma of the oral cavity and the oropharynx in patients less than 40 years of age: a 20-year analysis. Head Neck Oncol. 2012;4:28. doi:10.1186/1758-3284-4-28.

    Article  PubMed Central  PubMed  Google Scholar 

  61. Genden EM, Ferlito A, Bradley PJ, Rinaldo A, Scully C. Neck disease and distant metastases. Oral Oncol. 2003;39(3):207–12.

    Article  PubMed  Google Scholar 

  62. Severino P, Alvares AM, Michaluart Jr P, Okamoto OK, Nunes FD, Moreira-Filho CA, et al. Global gene expression profiling of oral cavity cancers suggests molecular heterogeneity within anatomic subsites. BMC Res Notes. 2008;1:113. doi:10.1186/1756-0500-1-113.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  63. Idikio HA. Immunohistochemistry in diagnostic surgical pathology: contributions of protein life-cycle, use of evidence-based methods and data normalization on interpretation of immunohistochemical stains. Int J Clin Exp Pathol. 2009;3(2):169–76.

    PubMed Central  PubMed  Google Scholar 

  64. Atkins D, Reiffen KA, Tegtmeier CL, Winther H, Bonato MS, Storkel S. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem Off J Histochem Soc. 2004;52(7):893–901. doi:10.1369/jhc.3A6195.2004.

    Article  CAS  Google Scholar 

  65. Gill S, Sargent D. End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival? Oncologist. 2006;11(6):624–9. doi:10.1634/theoncologist.11-6-624.

    Article  PubMed  CAS  Google Scholar 

  66. Zandberg DP, Bhargava R, Badin S, Cullen KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013;63(1):57–81. doi:10.3322/caac.21167.

    Article  PubMed  Google Scholar 

  67. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi:10.1056/NEJMoa0912217.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  68. Pazdur R. Endpoints for assessing drug activity in clinical trials. Oncologist. 2008;13 Suppl 2:19–21. doi:10.1634/theoncologist.13-S2-19.

    Article  PubMed  Google Scholar 

  69. Rabinowits G, Haddad RI. Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature. Oral Oncol. 2012;48(11):1085–9. doi:10.1016/j.oraloncology.2012.06.016.

    Article  PubMed  CAS  Google Scholar 

  70. Haura EB, Zheng Z, Song L, Cantor A, Bepler G. Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11(23):8288–94. doi:10.1158/1078-0432.CCR-05-0827.

    Article  CAS  Google Scholar 

  71. Markovic A, Chung CH. Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther. 2012;12(9):1149–59. doi:10.1586/era.12.91.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  72. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323(7306):224–8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  73. Altman DG, Lausen B, Sauerbrei W, Schumacher M. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86(11):829–35.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was supported by the grant from National Natural Science Foundation of China (No. 81172561)

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Medicine, Zhejiang University, Hangzhou, 310000, China

    Shen Keren

  2. Department of Otorhinolaryngology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, China

    Zhang Shoude, Zhao Lu & Yang Beibei

Authors
  1. Shen Keren
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhang Shoude
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhao Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yang Beibei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yang Beibei.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Keren, S., Shoude, Z., Lu, Z. et al. Role of EGFR as a prognostic factor for survival in head and neck cancer: a meta-analysis. Tumor Biol. 35, 2285–2295 (2014). https://doi.org/10.1007/s13277-013-1303-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1303-0

Keywords

Search

Navigation